Adaptimmune Therapeutics PLC (NAS:ADAP)
$ 0.9961 -0.02 (-1.98%) Market Cap: 254.75 Mil Enterprise Value: 87.31 Mil PE Ratio: 0 PB Ratio: 2.64 GF Score: 63/100

Adaptimmune Therapeutics PLC (ADAP) Transcripts

  • 1